▶ 調査レポート

抗炎症性腸疾患治療薬のアメリカ市場2017

• 英文タイトル:United States Inflammatory Bowel Disease Drugs Market Report 2017

QYResearchが調査・発行した産業分析レポートです。抗炎症性腸疾患治療薬のアメリカ市場2017 / United States Inflammatory Bowel Disease Drugs Market Report 2017 / A042116029資料のイメージです。• レポートコード:A042116029
• 出版社/出版日:QYResearch / 2017年3月2日
• レポート形態:英文、PDF、111ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医療・製薬・バイオ
• 販売価格(消費税別)
  Single User¥410,400 (USD3,800)▷ お問い合わせ
  Enterprise¥820,800 (USD7,600)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、抗炎症性腸疾患治療薬のアメリカ市場について調査・分析し、抗炎症性腸疾患治療薬のアメリカ市場概観、抗炎症性腸疾患治療薬の種類別市場分析、用途別市場分析、抗炎症性腸疾患治療薬のアメリカ市場規模予測、関連企業分析、関連企業情報、価格情報、販売動向、アメリカ市場動向、貿易動向、市場環境分析情報などを含め、以下の構成でお届けいたします。

・抗炎症性腸疾患治療薬のアメリカ市場概観
・抗炎症性腸疾患治療薬の種類別市場規模
・抗炎症性腸疾患治療薬の用途別市場規模
・抗炎症性腸疾患治療薬のアメリカ市場規模
・抗炎症性腸疾患治療薬のアメリカ市場予測
・抗炎症性腸疾患治療薬の製造メーカー分析
・抗炎症性腸疾患治療薬のメーカー別生産量
・抗炎症性腸疾患治療薬のメーカー別市場シェア
・抗炎症性腸疾患治療薬の価格動向・価格分析
・抗炎症性腸疾患治療薬の販売(売上高)動向
・抗炎症性腸疾患治療薬の貿易(輸出・輸入)動向
・抗炎症性腸疾患治療薬の産業チェーン分析
・抗炎症性腸疾患治療薬のマーケティング戦略分析
・抗炎症性腸疾患治療薬の販売業者(代理店)リスト
・抗炎症性腸疾患治療薬の市場環境分析
...

Notes:Sales, means the sales volume of Inflammatory Bowel Disease Drugs
Revenue, means the sales value of Inflammatory Bowel Disease Drugs

This report studies sales (consumption) of Inflammatory Bowel Disease Drugs in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
Abbvie
Biogen Idec
Janssen Pharmaceuticals
Merck
Novartis
Shire
UCB
Pfizer
Amgen
Akebia Therapeutics
Boehringer Ingelheim
Celltrion
ChemoCentryx
Ferring Pharmaceuticals
Galapagos
Genentech
Mitsubishi Tanabe
Novo Nordisk
Salix Pharmaceuticals

Market Segment by States, covering
California
Texas
New York
Florida
Illinois
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Oral
Parenteral
Split by applications, this report focuses on sales, market share and growth rate of Inflammatory Bowel Disease Drugs in each application, can be divided into
Hospital
Clinic

レポート目次

Table of Contents

United States Inflammatory Bowel Disease Drugs Market Report 2017
1 Inflammatory Bowel Disease Drugs Overview
1.1 Product Overview and Scope of Inflammatory Bowel Disease Drugs
1.2 Classification of Inflammatory Bowel Disease Drugs
1.2.1 Oral
1.2.2 Parenteral
1.3 Application of Inflammatory Bowel Disease Drugs
1.3.1 Hospital
1.3.2 Clinic
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Inflammatory Bowel Disease Drugs (2012-2022)
1.4.1 United States Inflammatory Bowel Disease Drugs Sales and Growth Rate (2012-2022)
1.4.2 United States Inflammatory Bowel Disease Drugs Revenue and Growth Rate (2012-2022)

2 United States Inflammatory Bowel Disease Drugs Competition by Manufacturers
2.1 United States Inflammatory Bowel Disease Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Inflammatory Bowel Disease Drugs Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Inflammatory Bowel Disease Drugs Average Price by Manufactures (2015 and 2016)
2.4 Inflammatory Bowel Disease Drugs Market Competitive Situation and Trends
2.4.1 Inflammatory Bowel Disease Drugs Market Concentration Rate
2.4.2 Inflammatory Bowel Disease Drugs Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion

3 United States Inflammatory Bowel Disease Drugs Sales (Volume) and Revenue (Value) by States (2012-2017)
3.1 United States Inflammatory Bowel Disease Drugs Sales and Market Share by States (2012-2017)
3.2 United States Inflammatory Bowel Disease Drugs Revenue and Market Share by States (2012-2017)
3.3 United States Inflammatory Bowel Disease Drugs Price by States (2012-2017)

4 United States Inflammatory Bowel Disease Drugs Sales (Volume) and Revenue (Value) by Type (2012-2017)
4.1 United States Inflammatory Bowel Disease Drugs Sales and Market Share by Type (2012-2017)
4.2 United States Inflammatory Bowel Disease Drugs Revenue and Market Share by Type (2012-2017)
4.3 United States Inflammatory Bowel Disease Drugs Price by Type (2012-2017)
4.4 United States Inflammatory Bowel Disease Drugs Sales Growth Rate by Type (2012-2017)

5 United States Inflammatory Bowel Disease Drugs Sales (Volume) by Application (2012-2017)
5.1 United States Inflammatory Bowel Disease Drugs Sales and Market Share by Application (2012-2017)
5.2 United States Inflammatory Bowel Disease Drugs Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Inflammatory Bowel Disease Drugs Manufacturers Profiles/Analysis
6.1 Abbvie
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Inflammatory Bowel Disease Drugs Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Abbvie Inflammatory Bowel Disease Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Biogen Idec
6.2.2 Inflammatory Bowel Disease Drugs Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Biogen Idec Inflammatory Bowel Disease Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Janssen Pharmaceuticals
6.3.2 Inflammatory Bowel Disease Drugs Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Janssen Pharmaceuticals Inflammatory Bowel Disease Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Merck
6.4.2 Inflammatory Bowel Disease Drugs Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Merck Inflammatory Bowel Disease Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Novartis
6.5.2 Inflammatory Bowel Disease Drugs Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Novartis Inflammatory Bowel Disease Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Shire
6.6.2 Inflammatory Bowel Disease Drugs Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Shire Inflammatory Bowel Disease Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 UCB
6.7.2 Inflammatory Bowel Disease Drugs Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 UCB Inflammatory Bowel Disease Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Pfizer
6.8.2 Inflammatory Bowel Disease Drugs Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Pfizer Inflammatory Bowel Disease Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Amgen
6.9.2 Inflammatory Bowel Disease Drugs Product Type, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Amgen Inflammatory Bowel Disease Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Akebia Therapeutics
6.10.2 Inflammatory Bowel Disease Drugs Product Type, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Akebia Therapeutics Inflammatory Bowel Disease Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Boehringer Ingelheim
6.12 Celltrion
6.13 ChemoCentryx
6.14 Ferring Pharmaceuticals
6.15 Galapagos
6.16 Genentech
6.17 Mitsubishi Tanabe
6.18 Novo Nordisk
6.19 Salix Pharmaceuticals

7 Inflammatory Bowel Disease Drugs Manufacturing Cost Analysis
7.1 Inflammatory Bowel Disease Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Inflammatory Bowel Disease Drugs

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Inflammatory Bowel Disease Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Inflammatory Bowel Disease Drugs Major Manufacturers in 2015
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Inflammatory Bowel Disease Drugs Market Forecast (2017-2022)
11.1 United States Inflammatory Bowel Disease Drugs Sales, Revenue Forecast (2017-2022)
11.2 United States Inflammatory Bowel Disease Drugs Sales Forecast by Type (2017-2022)
11.3 United States Inflammatory Bowel Disease Drugs Sales Forecast by Application (2017-2022)
11.4 Inflammatory Bowel Disease Drugs Price Forecast (2017-2022)

12 Research Findings and Conclusion

13 Appendix
Methodology
Analyst Introduction
Data Source

List of Tables and Figures

Figure Picture of Inflammatory Bowel Disease Drugs
Table Classification of Inflammatory Bowel Disease Drugs
Figure United States Sales Market Share of Inflammatory Bowel Disease Drugs by Type in 2015
Figure Oral Picture
Figure Parenteral Picture
Table Application of Inflammatory Bowel Disease Drugs
Figure United States Sales Market Share of Inflammatory Bowel Disease Drugs by Application in 2015
Figure Hospital Examples
Figure Clinic Examples
Figure United States Inflammatory Bowel Disease Drugs Sales and Growth Rate (2012-2022)
Figure United States Inflammatory Bowel Disease Drugs Revenue and Growth Rate (2012-2022)
Table United States Inflammatory Bowel Disease Drugs Sales of Key Manufacturers (2015 and 2016)
Table United States Inflammatory Bowel Disease Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Inflammatory Bowel Disease Drugs Sales Share by Manufacturers
Figure 2016 Inflammatory Bowel Disease Drugs Sales Share by Manufacturers
Table United States Inflammatory Bowel Disease Drugs Revenue by Manufacturers (2015 and 2016)
Table United States Inflammatory Bowel Disease Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Inflammatory Bowel Disease Drugs Revenue Share by Manufacturers
Table 2016 United States Inflammatory Bowel Disease Drugs Revenue Share by Manufacturers
Table United States Market Inflammatory Bowel Disease Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Inflammatory Bowel Disease Drugs Average Price of Key Manufacturers in 2015
Figure Inflammatory Bowel Disease Drugs Market Share of Top 3 Manufacturers
Figure Inflammatory Bowel Disease Drugs Market Share of Top 5 Manufacturers
Table United States Inflammatory Bowel Disease Drugs Sales by States (2012-2017)
Table United States Inflammatory Bowel Disease Drugs Sales Share by States (2012-2017)
Figure United States Inflammatory Bowel Disease Drugs Sales Market Share by States in 2015
Table United States Inflammatory Bowel Disease Drugs Revenue and Market Share by States (2012-2017)
Table United States Inflammatory Bowel Disease Drugs Revenue Share by States (2012-2017)
Figure Revenue Market Share of Inflammatory Bowel Disease Drugs by States (2012-2017)
Table United States Inflammatory Bowel Disease Drugs Price by States (2012-2017)
Table United States Inflammatory Bowel Disease Drugs Sales by Type (2012-2017)
Table United States Inflammatory Bowel Disease Drugs Sales Share by Type (2012-2017)
Figure United States Inflammatory Bowel Disease Drugs Sales Market Share by Type in 2015
Table United States Inflammatory Bowel Disease Drugs Revenue and Market Share by Type (2012-2017)
Table United States Inflammatory Bowel Disease Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Inflammatory Bowel Disease Drugs by Type (2012-2017)
Table United States Inflammatory Bowel Disease Drugs Price by Type (2012-2017)
Figure United States Inflammatory Bowel Disease Drugs Sales Growth Rate by Type (2012-2017)
Table United States Inflammatory Bowel Disease Drugs Sales by Application (2012-2017)
Table United States Inflammatory Bowel Disease Drugs Sales Market Share by Application (2012-2017)
Figure United States Inflammatory Bowel Disease Drugs Sales Market Share by Application in 2015
Table United States Inflammatory Bowel Disease Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Inflammatory Bowel Disease Drugs Sales Growth Rate by Application (2012-2017)
Table Abbvie Basic Information List
Table Abbvie Inflammatory Bowel Disease Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Abbvie Inflammatory Bowel Disease Drugs Sales Market Share (2012-2017)
Table Biogen Idec Basic Information List
Table Biogen Idec Inflammatory Bowel Disease Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Biogen Idec Inflammatory Bowel Disease Drugs Sales Market Share (2012-2017)
Table Janssen Pharmaceuticals Basic Information List
Table Janssen Pharmaceuticals Inflammatory Bowel Disease Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Janssen Pharmaceuticals Inflammatory Bowel Disease Drugs Sales Market Share (2012-2017)
Table Merck Basic Information List
Table Merck Inflammatory Bowel Disease Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Merck Inflammatory Bowel Disease Drugs Sales Market Share (2012-2017)
Table Novartis Basic Information List
Table Novartis Inflammatory Bowel Disease Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Novartis Inflammatory Bowel Disease Drugs Sales Market Share (2012-2017)
Table Shire Basic Information List
Table Shire Inflammatory Bowel Disease Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Shire Inflammatory Bowel Disease Drugs Sales Market Share (2012-2017)
Table UCB Basic Information List
Table UCB Inflammatory Bowel Disease Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table UCB Inflammatory Bowel Disease Drugs Sales Market Share (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Inflammatory Bowel Disease Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Pfizer Inflammatory Bowel Disease Drugs Sales Market Share (2012-2017)
Table Amgen Basic Information List
Table Amgen Inflammatory Bowel Disease Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Amgen Inflammatory Bowel Disease Drugs Sales Market Share (2012-2017)
Table Akebia Therapeutics Basic Information List
Table Akebia Therapeutics Inflammatory Bowel Disease Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Akebia Therapeutics Inflammatory Bowel Disease Drugs Sales Market Share (2012-2017)
Table Boehringer Ingelheim Basic Information List
Table Celltrion Basic Information List
Table ChemoCentryx Basic Information List
Table Ferring Pharmaceuticals Basic Information List
Table Galapagos Basic Information List
Table Genentech Basic Information List
Table Mitsubishi Tanabe Basic Information List
Table Novo Nordisk Basic Information List
Table Salix Pharmaceuticals Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Inflammatory Bowel Disease Drugs
Figure Manufacturing Process Analysis of Inflammatory Bowel Disease Drugs
Figure Inflammatory Bowel Disease Drugs Industrial Chain Analysis
Table Raw Materials Sources of Inflammatory Bowel Disease Drugs Major Manufacturers in 2015
Table Major Buyers of Inflammatory Bowel Disease Drugs
Table Distributors/Traders List
Figure United States Inflammatory Bowel Disease Drugs Production and Growth Rate Forecast (2017-2022)
Figure United States Inflammatory Bowel Disease Drugs Revenue and Growth Rate Forecast (2017-2022)
Table United States Inflammatory Bowel Disease Drugs Production Forecast by Type (2017-2022)
Table United States Inflammatory Bowel Disease Drugs Consumption Forecast by Application (2017-2022)
Table United States Inflammatory Bowel Disease Drugs Sales Forecast by States (2017-2022)
Table United States Inflammatory Bowel Disease Drugs Sales Share Forecast by States (2017-2022)